IL1B and age-related macular degeneration: Luteolin, known primarily for its anti-inflammatory activity, protects RPE cells from oxidative stress-induced cell death, mitigates epithelial-mesenchymal transformation, and suppresses IL-1β-induced adhesion in AMD [48–50].